What is the price-to-earnings ratio of Avicanna?
The price-earnings ratio of Avicanna is currently 10.81.
Avicanna P/E 2024
Avicanna P/E
10.81
Ticker
AVCN.TO
ISIN
CA05368K1003
WKN
A2PN04
As of Jul 17, 2024, Avicanna's P/E ratio was 10.81, a -418.88% change from the -3.39 P/E ratio recorded in the previous year.
The Avicanna P/E history
Avicanna Aktienanalyse
What does Avicanna do?
Avicanna Inc is a Canadian biopharmaceutical company specializing in the research, development, and manufacturing of medical marijuana products. The company was founded in 2016 by its president and CEO Aras Azadian, who has extensive experience in the pharmaceutical and biotechnology industry. The company is based in Toronto, Canada and also operates in Colombia and Switzerland. Avicanna has several subsidiaries, including Santa Marta Golden Hemp, which operates its cultivation business in Colombia. Avicanna's business model is focused on producing medical marijuana products that have better efficacy and tolerability than conventional products. The company uses a specialized process called PhytoVista™ to isolate and extract the active ingredients in plant extracts. Avicanna operates in various sectors, including the manufacturing and marketing of medical marijuana products, research and development of effective medical treatments, and collaboration with healthcare facilities and government agencies in marijuana regulation. The company offers a variety of products, including different types of hemp oil, CBD products, and pharmaceutical products such as Rho PhytoTM and Pura EarthTM. These products all share the common approach of providing patients with better, more effective, and tolerable treatment options. Rho PhytoTM is a patented medical marijuana product by Avicanna, derived from a specific cannabis strain called ACMPR. This product is approved in Canada and available as an oral solution and syringe. Rho PhytoTM is specifically tailored to meet the needs of patients with neurodegenerative diseases and has proven to be effective. Pura EarthTM is a herbal remedy derived from the medical marijuana plant and is intended to be used as an alternative medicine for pain and inflammation. In addition to manufacturing medical marijuana products, the company also conducts intensive research and development to develop medications based on synthetic cannabinoids. These substances have the potential to help patients with various conditions such as multiple sclerosis, epilepsy, and tumor diseases. Avicanna also has partnerships with various healthcare facilities and government agencies to advance the regulation of medical marijuana and ensure the safety and efficacy of these products. In summary, Avicanna is an innovative biopharmaceutical company specializing in the manufacturing and marketing of medical marijuana products. The company serves various areas within the marijuana industry, including the production of medical products, research and development, and regulation of marijuana products. With an extensive product range and a strong research and development department, Avicanna is well positioned to continue growing and developing more innovative products in the coming years. Avicanna ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Avicanna's P/E Ratio
The Price to Earnings (P/E) Ratio of Avicanna is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Avicanna's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Avicanna is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Avicanna’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Avicanna stock
How has the price-earnings ratio of Avicanna changed compared to last year?
The price-to-earnings ratio of Avicanna has increased by -418.88% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Avicanna high compared to other companies?
Yes, the price-to-earnings ratio of Avicanna is high compared to other companies.
How does an increase in the price-earnings ratio of Avicanna affect the company?
An increase in the price-earnings ratio of Avicanna would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Avicanna affect the company?
A decrease in the price-earnings ratio of Avicanna would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Avicanna?
Some factors that influence the price-earnings ratio of Avicanna are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Avicanna pay?
Over the past 12 months, Avicanna paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avicanna is expected to pay a dividend of 0 CAD.
What is the dividend yield of Avicanna?
The current dividend yield of Avicanna is .
When does Avicanna pay dividends?
Avicanna pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Avicanna?
Avicanna paid dividends every year for the past 0 years.
What is the dividend of Avicanna?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Avicanna located?
Avicanna is assigned to the 'Health' sector.
Wann musste ich die Aktien von Avicanna kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Avicanna from 7/17/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 7/17/2024.
When did Avicanna pay the last dividend?
The last dividend was paid out on 7/17/2024.
What was the dividend of Avicanna in the year 2023?
In the year 2023, Avicanna distributed 0 CAD as dividends.
In which currency does Avicanna pay out the dividend?
The dividends of Avicanna are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Avicanna stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Avicanna
Our stock analysis for Avicanna Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avicanna Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
